CASE STUDY: INJUNCTING MULTIPLE INFRINGERS
Our client, BASF, is the world’s largest chemical company. It holds a large number of patents for a range of chemical compounds, including around 200 patents for agrochemical compounds. Although the issues in this example relate to the agrochemical sector, the problems faced also occur in the pharmaceutical sector. read more…
CASE STUDY: REVOKING A PATENT
Our client, C, was a chemicals manufacturer which supplied precursors and API’s to a wide range of pharmaceutical companies, both major R&D based and generic manufacturers. C had a successful process for manufacturing an API that was the basis of a major blockbuster product, and a plant where it was scheduled to occupy a large proportion of manufacturing capacity. read more…
CASE STUDY: ENFORCING YOUR IP RIGHTS
This example relates to the agrochemical sector, but similar problems are faced in the pharmaceutical sector. Our client, A, was a major R&D based chemicals manufacturer with interests in agricultural chemicals. A was concerned about the activities of a well-funded UK-based individual, B, who had obtained marketing authorisation for various companies controlled by him to sell under their own names a parallel imported patented pesticide product manufactured by A. read more…
CASE STUDY: DEFENDING AN INJUNCTION APPLICATION
Our client is a generic pharmaceutical company. It wanted to launch a generic alternative of a formulation of a drug that was patented, in the UK and elsewhere. Its objectives were to ensure that no interim injunction was awarded against it; that if sued, it would be in the best position possible to defend the action and ultimately “win”; and to know where it stands as quickly as possible. read more…
CASE STUDY: MAXIMISING YOUR LICENCE REVENUES
Our client, D, was a small company that had been spun out of a University pharmacy department a few years previously. Its business depended upon a class of chemicals covered by patents that it owned, which had applications in a number of fields in addition to pharmaceuticals. The largest and most easily exploitable field appeared to be in the oil industry for increasing the recovery of oil from wells. read more…
CASE STUDY: CONVERTING A PRODUCT SUPPLY BUSINESS INTO A LICENSING BUSINESS
Our client was one of the leading drug delivery companies in the world specialising in particular in syringes with a substantial share of the worldwide market for the sale of syringes. It sold these as products. Although it had an extensive R&D and Patents department and had newly developed ground-breaking technology for “needleless injection”’ it had rarely, if ever, licensed “out” its technology. read more…